Evista vs. Breast Cancer?

Lila de Tantillo Health Guide
  • After intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its use against breast cancer. A related drug, Tamoxifen, is already widely used by breast cancer survivors. If approved this would be a particularly interesting development because breast cancer survivors at increased risk of osteoporosis, often because of their medication regimes for cancer. In contrast, this medicine might help protect their bones. Read more at: http://www.thestreet.com/s/fda-mulls-new-use-for-lilly-drug/newsanalysis/pharmaceuticals/10369172.html?puc=_googlen?cm_ven=GOOGLEN&cm_cat=FREE&cm_ite=NA
    Add This Infographic to Your Website or Blog With This Code:
Published On: July 24, 2007